The newspaper “El País” includes the announcement made by US President, Barack Obama, about the project to build a supercomputer capable of performing a trillion calculations per second. The article includes statements made by Modesto Orozco, Group Leader at IRB Barcelona, Director of Life Sciences at the BSC-CNS and Professor at the UB, who gives his opinion about the impact that this project might have on the field of biomedical research.
Read the article in El País (in Spanish)
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression
Combination of two strong denaturants of DNA leads to stabilization of the structure
An unexpected finding that opens new fields to the biotechnological use of DNA
A study, published today in the journal Nature, marks a milestone in the understanding of chronic lymphocytic leukemia (CLL)
CLL is the most frequent leukemia with more than 12,000 new cases diagnosed in Europe every year
IRB Barcelona group leader Modesto Orozco participated in the study as he is involved with the International Cancer Genome Consortium (ICGC)
The newspaper “El Periódico de Catalunya” has echoed the award ceremony of the 77 grants given by the “Obra Social La Caixa” foundation to support doctoral students. This grant programme aims to retain Spanish students and attract international students with talent for research, both for Spanish universities and Severo Ochoa centres. In this edition, IRB Barcelona students Jürgen Walther, Craig Donoghue, Elzbieta Szulc, and Lada Murcia received these awards.
The trilingual magazine of the city of Barcelona, Barcelona Metropolis, dedicates its leading article and an extensive report to the biomedicine conducted in Barcelona. Various articles in this edition address topics related to this discipline, ranging from biomedicine as a business model and associated research fields, such as biomedical chemistry or big data, to key institutions such as the Catalan Institution for Research and Advanced Studies (ICREA).
IRB Barcelona is well represented in the magazine, with references and statements by Joan Guinovart, director of the institute, Patrick Aloy, Eduard Batlle, Natàlia Carulla, Ernest Giralt, Modesto Orozco, and Xavier Salvatella,...
ELIXIR coordinates the storage, access and development of the software needed to understand biological data
Six institutions coordinated through the INB, whose central node is hosted at the CNIO, will participate in the European infrastructure
The electric polarizability of DNA is a fundamental property that directly influences its biological functions. Despite the importance of this property, however, its measurement has remained elusive so far.
In a study published in PNAS today, researchers at Barcelona’s Institute for Bioengineering of Catalonia (IBEC) led by Laura Fumagalli, senior researcher at IBEC and lecturer at the University of Barcelona, and their collaborators at the Institute for Research in Biomedicine (IRB) and at Barcelona Supercomputing Center (BSC), and at Centro Nacional de Biotecnologia (CNB-CSIC) and IMDEA Nanociencia in Madrid, describe how they have found a way to directly measure DNA electric polarizability – represented by its dielectric constant, which indicates how a material reacts to an applied electric field – for the first time ever.
Genetic Engineering & Biotechnology News (GEN) devotes a news item to the recent study by IRB Barcelona scientists Xavier Salvatella and Modesto Orozco.
Published in Nature Communications, the study reports the team's discovery that the motions of various parts of proteins, although physically far apart, are correlated. Such findings hint at another way to think about drug development.
Read the news in...
A study by the scientists Xavier Salvatella and Modesto Orozco at IRB Barcelona reveals the existence of information highways that connect and correlate distant sites within a single protein.
Published in Nature Communications, the article furthers a key theoretical field for drug discovery, as it would allow the discovery of many more drug binding sites in proteins of biomedical interest.